144 related articles for article (PubMed ID: 20974723)
1. Meloxicam-induced enteropathy of the small bowel.
Are C; Turagam M; Aucar JA; Greenberg E
CMAJ; 2011 Mar; 183(5):577-80. PubMed ID: 20974723
[No Abstract] [Full Text] [Related]
2. Multiple Colon Ulcers with Typical Small Intestinal Lesions Induced by Non-Steroidal Anti-Inflammatory Drugs.
Akashi M; Ando T; Hamashima T; Yoshita H; Nanjo S; Mihara H; Fujinami H; Kajiura S; Nishikawa J; Miura Y; Hosokawa A; Sugiyama T
Intern Med; 2015; 54(16):1995-9. PubMed ID: 26278290
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy and intolerance of meloxicam in injection and tablet form].
Tiurin VP; Rakov AL
Voen Med Zh; 2003 Nov; 324(11):54-8. PubMed ID: 14725079
[No Abstract] [Full Text] [Related]
4. [Meloxicam: intramuscular administration in rheumatology].
Tsvetkova ES
Ter Arkh; 2003; 75(8):96-7. PubMed ID: 14520864
[No Abstract] [Full Text] [Related]
5. Small bowel injury induced by selective cyclooxygenase-2 inhibitors: a prospective, double-blind, randomized clinical trial comparing celecoxib and meloxicam.
Maehata Y; Esaki M; Morishita T; Kochi S; Endo S; Shikata K; Kobayashi H; Matsumoto T
J Gastroenterol; 2012 Apr; 47(4):387-93. PubMed ID: 22170412
[TBL] [Abstract][Full Text] [Related]
6. A possible anaphylactoid reaction in a cow after intravenous meloxicam.
Okushima S; Chesnel MA; Clutton RE
Vet Anaesth Analg; 2013 May; 40(3):333-4. PubMed ID: 23438083
[No Abstract] [Full Text] [Related]
7. Ischaemic colitis in a patient taking meloxicam.
Garcia B; Ramaholimihaso F; Diebold MD; Cadiot G; Thiéfin G
Lancet; 2001 Mar; 357(9257):690. PubMed ID: 11247558
[TBL] [Abstract][Full Text] [Related]
8. Low-dose meloxicam (Vivlodex) for osteoarthritis pain.
Med Lett Drugs Ther; 2016 Mar; 58(1490):35-6. PubMed ID: 26963155
[No Abstract] [Full Text] [Related]
9. A 4-week, double-blind, parallel-group study to compare the gastrointestinal effects of meloxicam 7.5 mg, meloxicam 15 mg, piroxicam 20 mg and placebo by means of faecal blood loss, endoscopy and symptom evaluation in healthy volunteers.
Patoia L; Santucci L; Furno P; Dionisi MS; Dell'Orso S; Romagnoli M; Sattarinia A; Marini MG
Br J Rheumatol; 1996 Apr; 35 Suppl 1():61-7. PubMed ID: 8630640
[TBL] [Abstract][Full Text] [Related]
10. [Rheumatic disease therapy without regret. Meloxicam dosage safety].
MMW Fortschr Med; 2002 Nov; 144(46):66-7. PubMed ID: 12534086
[No Abstract] [Full Text] [Related]
11. Letter to the Editor: Acute kidney injury following subcutaneous meloxicam administration.
Malik R; Wun MK; King T; Korman R
J Vet Pharmacol Ther; 2024 May; 47(3):235-236. PubMed ID: 38426603
[No Abstract] [Full Text] [Related]
12. Reply to: Letter to the Editor from Malik et al.: Acute kidney injury following subcutaneous meloxicam administration.
Krekis A; King JN; D'Arcy-Howard D; Stapleton N; Elliott J; Pelligand L
J Vet Pharmacol Ther; 2024 May; 47(3):237-238. PubMed ID: 38462540
[No Abstract] [Full Text] [Related]
13. Review of clinical trials and benefit/risk ratio of meloxicam.
Barner A
Scand J Rheumatol Suppl; 1996; 102():29-37. PubMed ID: 8628979
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal complications and meloxicam.
Fenn GC; Morant SV; Shield MJ
Br J Rheumatol; 1997 Nov; 36(11):1234. PubMed ID: 9402874
[No Abstract] [Full Text] [Related]
15. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
Singh G; Lanes S; Triadafilopoulos G
Am J Med; 2004 Jul; 117(2):100-6. PubMed ID: 15234645
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal tolerability of meloxicam and piroxicam: a double-blind placebo-controlled study.
Lipscomb GR; Wallis N; Armstrong G; Rees WD
Br J Clin Pharmacol; 1998 Aug; 46(2):133-7. PubMed ID: 9723821
[TBL] [Abstract][Full Text] [Related]
17. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
Lindén B; Distel M; Bluhmki E
Br J Rheumatol; 1996 Apr; 35 Suppl 1():35-8. PubMed ID: 8630634
[TBL] [Abstract][Full Text] [Related]
18. Meloxicam: a review of its pharmacokinetics, efficacy and tolerability following intramuscular administration.
Euller-Ziegler L; Vélicitat P; Bluhmki E; Türck D; Scheuerer S; Combe B
Inflamm Res; 2001 Mar; 50 Suppl 1():S5-9. PubMed ID: 11339521
[TBL] [Abstract][Full Text] [Related]
19. [Observations on the side effects after application of non-steroidal anti-inflammatory agents in dogs].
Gassner G; Stephan I; Schütt-Mast I
Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Apr; 26(2):119-23. PubMed ID: 9587983
[TBL] [Abstract][Full Text] [Related]
20. [The selective cox-2 inhibitor meloxicam and salicylate therapy].
Tóth K
Ideggyogy Sz; 2005 May; 58(5-6):173-4. PubMed ID: 16021964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
